Composition and function of the pediatric colonic mucosal microbiome in untreated patients with ulcerative colitis

Gut Microbes

Volumn 7, Issue 5, 2016, Pages 384-396

  Shah, Rajesh ^a   Cope, Julia L ^a,b   Nagy Szakal, Dorottya ^a,b   Dowd, Scot ^c   Versalovic, James ^a,b   Hollister, Emily B ^a,b   Kellermayer, Richard ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c Molecular Research (MR DNA)   (United States)

Author keywords

Inflammatory bowel disease; metagenome; microbiome; microbiota; ulcerative colitis

Indexed keywords

SHORT CHAIN FATTY ACID;

ARTICLE; COLON BIOPSY; CONTROLLED STUDY; DNA EXTRACTION; FAECALIBACTERIUM PRAUSNITZII; FEMALE; GENE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; MALE; MICROBIOME; ORAL BIOPSY; PHYLOGENY; RNA 16S GENE; ULCERATIVE COLITIS; ADOLESCENT; BACTERIUM; CHILD; CLASSIFICATION; GENETICS; INTESTINE; INTESTINE FLORA; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOPHYSIOLOGY; PEDIATRICS; PRESCHOOL CHILD;

ADOLESCENT; BACTERIA; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINAL MUCOSA; INTESTINES; MALE; PEDIATRICS; PHYLOGENY;

EID: 84979512961     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2016.1190073     Document Type: Article

References (63)

1. J.Li, J.Butcher, D.Mack, A.Stintzi. Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 2015; 21:139-53; PMID:25248007; http://dx.doi.org/10.1097/MIB.0000000000000215
2. L.Jostins, S.Ripke, R.K.Weersma, R.H.Duerr, D.P.McGovern, K.Y.Hui, J.C.Lee, L.P.Schumm, Y.Sharma, C.A.Anderson, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491:119-24; PMID:23128233; http://dx.doi.org/10.1038/nature11582
3. D.N.Frank, C.E.Robertson, C.M.Hamm, Z.Kpadeh, T.Zhang, H.Chen, W.Zhu, R.B.Sartor, E.C.Boedeker, N.Harpaz, et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2011; 17:179-84; PMID:20839241; http://dx.doi.org/10.1002/ibd.21339
4. B.P.Willing, J.Dicksved, J.Halfvarson, A.F.Andersson, M.Lucio, Z.Zheng, G.Jarnerot, C.Tysk, J.K.Jansson, L.Engstrand. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010; 139:1844-54 e1; PMID:20816835; http://dx.doi.org/10.1053/j.gastro.2010.08.049
5. S.J.Ott, M.Musfeldt, D.F.Wenderoth, J.Hampe, O.Brant, U.R.Folsch, K.N.Timmis, S.Schreiber. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004; 53:685-93; PMID:15082587; http://dx.doi.org/10.1136/gut.2003.025403
6. D.N.Frank, A.L.St Amand, R.A.Feldman, E.C.Boedeker, N.Harpaz, N.R.Pace. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007; 104:13780-5; PMID:17699621; http://dx.doi.org/10.1073/pnas.0706625104
7. P.Lepage, P.Seksik, M.Sutren, M.-F.de la Cochetière, R.Jian, P.Marteau, J.Doré. Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with Ibd. Inflamm Bowel Dis 2005; 11:473-80; PMID:15867587; http://dx.doi.org/10.1097/01.MIB.0000159662.62651.06
8. R.Bibiloni, M.Mangold, K.L.Madsen, R.N.Fedorak, G.W.Tannock. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol 2006; 55:1141-9; PMID:16849736; http://dx.doi.org/10.1099/jmm.0.46498-0
9. E.Varela, C.Manichanh, M.Gallart, A.Torrejon, N.Borruel, F.Casellas, F.Guarner, M.Antolin. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis. Aliment Pharmacol Ther 2013; 38:151-61; PMID:23725320; http://dx.doi.org/10.1111/apt.12365
10. R.Hansen, R.K.Russell, C.Reiff, P.Louis, F.McIntosh, S.H.Berry, I.Mukhopadhya, W.M.Bisset, A.R.Barclay, J.Bishop, et al. Microbiota of de-novo pediatric IBD:increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am J Gastroenterol 2012; 107:1913-22; PMID:23044767; http://dx.doi.org/10.1038/ajg.2012.335
11. S.Michail, M.Durbin, D.Turner, A.M.Griffiths, D.R.Mack, J.Hyams, N.Leleiko, H.Kenche, A.Stolfi, E.Wine. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis 2012; 18:1799-808; PMID:22170749; http://dx.doi.org/10.1002/ibd.22860
12. P.Lepage, R.Hasler, M.E.Spehlmann, A.Rehman, A.Zvirbliene, A.Begun, S.Ott, L.Kupcinskas, J.Dore, A.Raedler, et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 2011; 141:227-36; PMID:21621540; http://dx.doi.org/10.1053/j.gastro.2011.04.011
13. S.J.Ott, S.Plamondon, A.Hart, A.Begun, A.Rehman, M.A.Kamm, S.Schreiber. Dynamics of the mucosa-associated flora in ulcerative colitis patients during remission and clinical relapse. J Clin Microbiol 2008; 46:3510-3; PMID:18701655; http://dx.doi.org/10.1128/JCM.01512-08
14. H.Sokol, B.Pigneur, L.Watterlot, O.Lakhdari, L.G.Bermudez-Humaran, J.J.Gratadoux, S.Blugeon, C.Bridonneau, J.P.Furet, G.Corthier, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008; 105:16731-6; PMID:18936492; http://dx.doi.org/10.1073/pnas.0804812105
15. L.Chen, W.Wang, R.Zhou, S.C.Ng, J.Li, M.Huang, F.Zhou, X.Wang, B.Shen, M.A. M AK, et al. Characteristics of fecal and mucosa-associated microbiota in chinese patients with inflammatory bowel disease. Medicine 2014; 93:e51; PMID:25121355; http://dx.doi.org/10.1097/MD.0000000000000051
16. A.Fite, S.Macfarlane, E.Furrie, B.Bahrami, J.H.Cummings, D.T.Steinke, G.T.Macfarlane. Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration. J Clin Microbiol 2013; 51:849-56; PMID:23269735; http://dx.doi.org/10.1128/JCM.02574-12
17. K.Machiels, M.Joossens, J.Sabino, V.De Preter, I.Arijs, V.Eeckhaut, V.Ballet, K.Claes, F.Van Immerseel, K.Verbeke, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2014; 63:1275-83; PMID:24021287; http://dx.doi.org/10.1136/gutjnl-2013-304833
18. M.Lopez-Siles, M.Martinez-Medina, D.Busquets, M.Sabat-Mir, S.H.Duncan, H.J.Flint, X.Aldeguer, L.J.Garcia-Gil. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes. Int J Med Microbiol 2014; 304:464-75; PMID:24713205; http://dx.doi.org/10.1016/j.ijmm.2014.02.009
19. M.Wang, G.Molin, S.Ahrne, D.Adawi, B.Jeppsson. High proportions of proinflammatory bacteria on the colonic mucosa in a young patient with ulcerative colitis as revealed by cloning and sequencing of 16S rRNA genes. Dig Dis Sci 2007; 52:620-7; PMID:17265126; http://dx.doi.org/10.1007/s10620-006-9461-1
20. X.C.Morgan, T.L.Tickle, H.Sokol, D.Gevers, K.L.Devaney, D.V.Ward, J.A.Reyes, S.A.Shah, N.LeLeiko, S.B.Snapper, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012; 13:R79; PMID:23013615; http://dx.doi.org/10.1186/gb-2012-13-9-r79
21. F.C.Nwosu, L.T.Thorkildsen, E.Avershina, P.Ricanek, G.Perminow, S.Brackmann, M.H.Vatn, K.Rudi. Age-dependent fecal bacterial correlation to inflammatory bowel disease for newly diagnosed untreated children. Gastroenterol Res Pract 2013; 2013:302398; PMID:23690761; http://dx.doi.org/10.1155/2013/302398
22. D.Gevers, S.Kugathasan, L.A.Denson, Y.Vazquez-Baeza, W.Van Treuren, B.Ren, E.Schwager, D.Knights, S.J.Song, M.Yassour, et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014; 15:382-92; PMID:24629344; http://dx.doi.org/10.1016/j.chom.2014.02.005
23. E.G.Zoetendal, A.von Wright, T.Vilpponen-Salmela, K.Ben-Amor, A.D.Akkermans, W.M.de Vos. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 2002; 68:3401-7; PMID:12089021; http://dx.doi.org/10.1128/AEM.68.7.3401-3407.2002
24. R.Kellermayer, S.A.Mir, D.Nagy-Szakal, S.B.Cox, S.E.Dowd, J.L.Kaplan, Y.Sun, S.Reddy, J.Bronsky, H.S.Winter. Microbiota separation and C-reactive protein elevation in treatment-naive pediatric granulomatous Crohn disease. J Pediatr Gastroenterol Nutr 2012; 55:243-50; PMID:22699834; http://dx.doi.org/10.1097/MPG.0b013e3182617c16
25. M.Derrien, E.E.Vaughan, C.M.Plugge, W.M.de Vos. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 2004; 54:1469-76; PMID:15388697; http://dx.doi.org/10.1099/ijs.0.02873-0
26. M.W.van Passel, R.Kant, E.G.Zoetendal, C.M.Plugge, M.Derrien, S.A.Malfatti, P.S.Chain, T.Woyke, A.Palva, W.M.de Vos, et al. The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PloS One 2011; 6:e16876; PMID:21390229
27. M.C.Collado, M.Derrien, E.Isolauri, W.M.de Vos, S.Salminen. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl Environ Microbiol 2007; 73:7767-70; PMID:17933936; http://dx.doi.org/10.1128/AEM.01477-07
28. M.Derrien, P.Van Baarlen, G.Hooiveld, E.Norin, M.Muller, W.M.de Vos. Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. Front Microbiol 2011; 2:166; PMID:21904534; http://dx.doi.org/10.3389/fmicb.2011.00166
29. C.W.Png, S.K.Linden, K.S.Gilshenan, E.G.Zoetendal, C.S.McSweeney, L.I.Sly, M.A.McGuckin, T.H.Florin. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 2010; 105:2420-8; PMID:20648002; http://dx.doi.org/10.1038/ajg.2010.281
30. M.Rajilic-Stojanovic, F.Shanahan, F.Guarner, W.M.de Vos. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm Bowel Dis 2013; 19:481-8; PMID:23385241; http://dx.doi.org/10.1097/MIB.0b013e31827fec6d
31. S.L.James, C.T.Christophersen, A.R.Bird, M.A.Conlon, O.Rosella, P.R.Gibson, J.G.Muir. Abnormal fibre usage in UC in remission. Gut 2014; 64:562-70; PMID:25037189; http://dx.doi.org/10.1136/gutjnl-2014-307198
32. L.K.Vigsnaes, J.Brynskov, C.Steenholdt, A.Wilcks, T.R.Licht. Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls. Benef Microbes 2012; 3:287-97; PMID:22968374; http://dx.doi.org/10.3920/BM2012.0018
33. A.E.Dorofeyev, I.V.Vasilenko, O.A.Rassokhina, R.B.Kondratiuk. Mucosal barrier in ulcerative colitis and Crohn's disease. Gastroenterol Res Pract 2013; 2013:431231; PMID:23737764; http://dx.doi.org/10.1155/2013/431231
34. B.P.Ganesh, R.Klopfleisch, G.Loh, M.Blaut. Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. PloS One 2013; 8:e74963; PMID:24040367
35. C.S.Kang, M.Ban, E.J.Choi, H.G.Moon, J.S.Jeon, D.K.Kim, S.K.Park, S.G.Jeon, T.Y.Roh, S.J.Myung, et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PloS One 2013; 8:e76520; PMID:24204633
36. A.Rehman, P.Rausch, J.Wang, J.Skieceviciene, G.Kiudelis, K.Bhagalia, D.Amarapurkar, L.Kupcinskas, S.Schreiber, P.Rosenstiel, et al. Geographical patterns of the standing and active human gut microbiome in health and IBD. Gut 2015; 65:238-48; PMID:25567118
37. P.Louis, G.L.Hold, H.J.Flint. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 2014; 12:661-72; PMID:25198138; http://dx.doi.org/10.1038/nrmicro3344
38. C.J.Kelly, L.Zheng, E.L.Campbell, B.Saeedi, C.C.Scholz, A.J.Bayless, K.E.Wilson, L.E.Glover, D.J.Kominsky, A.Magnuson, et al. Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. Cell Host Microbe 2015; PMID:25865369
39. R.Kumari, V.Ahuja, J.Paul. Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India. World J Gastroenterol 2013; 19:3404-14; PMID:23801832; http://dx.doi.org/10.3748/wjg.v19.i22.3404
40. T.D.Schaible, R.A.Harris, S.E.Dowd, C.W.Smith, R.Kellermayer. Maternal methyl-donor supplementation induces prolonged murine offspring colitis susceptibility in association with mucosal epigenetic and microbiomic changes. Hum Mol Genet 2011; 20:1687-96; PMID:21296867; http://dx.doi.org/10.1093/hmg/ddr044
41. H.S.Said, W.Suda, S.Nakagome, H.Chinen, K.Oshima, S.Kim, R.Kimura, A.Iraha, H.Ishida, J.Fujita, et al. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers. DNA Res 2014; 21:15-25; PMID:24013298; http://dx.doi.org/10.1093/dnares/dst037
42. C.H.Song, C.M.Vadheim, W.J.Snape, D.C.Heiner. Antibodies in patients with inflammatory bowel disease and the apparent influence of medications. J Clin Lab Immunol 1995; 46:143-54; PMID:8733027
43. M.Davenport, J.Poles, J.M.Leung, M.J.Wolff, W.M.Abidi, T.Ullman, L.Mayer, I.Cho, P.Loke. Metabolic alterations to the mucosal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 2014; 20:723-31; PMID:24583479; http://dx.doi.org/10.1097/MIB.0000000000000011
44. M.G.Langille, J.Zaneveld, J.G.Caporaso, D.McDonald, D.Knights, J.A.Reyes, J.C.Clemente, D.E.Burkepile, R.L.Vega Thurber, R.Knight, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013; 31:814-21; PMID:23975157; http://dx.doi.org/10.1038/nbt.2676
45. S.Rajca, V.Grondin, E.Louis, G.Vernier-Massouille, J.C.Grimaud, Y.Bouhnik, D.Laharie, J.L.Dupas, H.Pillant, L.Picon, et al. Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease. Inflamm Bowel Dis 2014; 20:978-86; PMID:24788220
46. G.A.Preidis, D.M.Saulnier, S.E.Blutt, T.A.Mistretta, K.P.Riehle, A.M.Major, S.F.Venable, M.J.Finegold, J.F.Petrosino, M.E.Conner, et al. Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB J 2012; 26:1960-9; PMID:22267340; http://dx.doi.org/10.1096/fj.10-177980
47. R.N.Carmody, G.K.Gerber, J.M.Luevano, Jr., D.M.Gatti, L.Somes, K.L.Svenson, P.J.Turnbaugh. Diet Dominates Host Genotype in Shaping the Murine Gut Microbiota. Cell Host Microbe 2014; PMID:25532804
48. J.G.Caporaso, J.Kuczynski, J.Stombaugh, K.Bittinger, F.D.Bushman, E.K.Costello, N.Fierer, A.G.Pena, J.K.Goodrich, J.I.Gordon, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010; 7:335-6; PMID:20383131; http://dx.doi.org/10.1038/nmeth.f.303
49. J.K.Goodrich, S.C.Di Rienzi, A.C.Poole, O.Koren, W.A.Walters, J.G.Caporaso, R.Knight, R.E.Ley. Conducting a microbiome study. Cell 2014; 158:250-62; PMID:25036628; http://dx.doi.org/10.1016/j.cell.2014.06.037
50. T.Z.DeSantis, P.Hugenholtz, N.Larsen, M.Rojas, E.L.Brodie, K.Keller, T.Huber, D.Dalevi, P.Hu, G.L.Andersen. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006; 72:5069-72; PMID:16820507; http://dx.doi.org/10.1128/AEM.03006-05
51. D.McDonald, M.N.Price, J.Goodrich, E.P.Nawrocki, T.Z.DeSantis, A.Probst, G.L.Andersen, R.Knight, P.Hugenholtz. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 2012; 6:610-8; PMID:22134646; http://dx.doi.org/10.1038/ismej.2011.139
52. B.J.Haas, D.Gevers, A.M.Earl, M.Feldgarden, D.V.Ward, G.Giannoukos, D.Ciulla, D.Tabbaa, S.K.Highlander, E.Sodergren, et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res 2011; 21:494-504; PMID:21212162; http://dx.doi.org/10.1101/gr.112730.110
53. C.Lozupone, R.Knight. UniFrac:a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 2005; 71:8228-35; PMID:16332807; http://dx.doi.org/10.1128/AEM.71.12.8228-8235.2005
54. Y.Vazquez-Baeza, M.Pirrung, A.Gonzalez, R.Knight. EMPeror:a tool for visualizing high-throughput microbial community data. GigaScience 2013; 2:16; PMID:24280061; http://dx.doi.org/10.1186/2047-217X-2-16
55. J.G.Caporaso, R.Knight, S.T.Kelley. Host-associated and free-living phage communities differ profoundly in phylogenetic composition. PloS One 2011; 6:e16900; PMID:21383980
56. J.Goecks, A.Nekrutenko, J.Taylor, T.Galaxy. Galaxy:a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 2010; 11:R86; PMID:20738864; http://dx.doi.org/10.1186/gb-2010-11-8-r86
57. D.Blankenberg, G.Von Kuster, N.Coraor, G.Ananda, R.Lazarus, M.Mangan, A.Nekrutenko, J.Taylor. Galaxy:a web-based genome analysis tool for experimentalists. Current protocols in molecular biology / edited by F.M.AusubelFrederick M [et al] 2010; Chapter 19:Unit 19 0 1-21.
58. T.Doerks, R.R.Copley, J.Schultz, C.P.Ponting, P.Bork. Systematic identification of novel protein domain families associated with nuclear functions. Genome Res 2002; 12:47-56; PMID:11779830; http://dx.doi.org/10.1101/gr.203201
59. M.Kanehisa, S.Goto. KEGG:kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28:27-30; PMID:10592173; http://dx.doi.org/10.1093/nar/28.1.27
60. M.Kanehisa, S.Goto, Y.Sato, M.Kawashima, M.Furumichi, M.Tanabe. Data, information, knowledge and principle:back to metabolism in KEGG. Nucleic Acids Res 2014; 42:D199-205; PMID:24214961; http://dx.doi.org/10.1093/nar/gkt1076
61. D.H.Parks, G.W.Tyson, P.Hugenholtz, R.G.Beiko. STAMP:statistical analysis of taxonomic and functional profiles. Bioinformatics 2014; 30:3123-4; PMID:25061070; http://dx.doi.org/10.1093/bioinformatics/btu494
62. N.Segata, J.Izard, L.Waldron, D.Gevers, L.Miropolsky, W.S.Garrett, C.Huttenhower. Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12:R60; PMID:21702898; http://dx.doi.org/10.1186/gb-2011-12-6-r60
63. J.R.White, N.Nagarajan, M.Pop. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol 2009; 5:e1000352; PMID:19360128; http://dx.doi.org/10.1371/journal.pcbi.1000352